# Laser Therapy for Non-Small Cell Lung Cancer

- Link: https://sifsof.com/clinical-apps/laser-therapy-for-non-small-cell-lung-cancer/
- Published: 2022-04-01T09:28:04+00:00
- Author: Monica

Non-small-cell lung cancer (NSCLC) is any type of epithelial lung cancer other 
than small cell lung cancer (SCLC). The most common types of NSCLC are squamous 
cell carcinoma, large cell carcinoma, and adenocarcinoma, but there are several 
other types that occur less frequently, and all types can occur in unusual histologic
variants.

The following factors may raise a person’s risk of developing NSCLC:

 * Tobacco and smoking. Tobacco smoke damages cells in the lungs, causing the cells
   to grow abnormally.

 * Asbestos.

 * Radon.

 * Air pollution.

 * Other substances.

 * Genetics.

The following are the most common lung cancer – Non-Small Cell symptoms and signs:

 * Fatigue.

 * Cough.

 * Shortness of breath.

 * Chest pain, is if a tumor spreads to the lining of the lung or other parts of
   the body near the lungs.

 * Loss of appetite.

 * Coughing up phlegm or mucus.

 * Coughing up blood.

 * Unintentional weight loss.

Radiation Therapy (laser therapy) for Non-Small Cell Lung Cancer has proved to be
one of the most suitable treatments.

To explain in more detail, The laser activates the light-sensitive drug within the
cancer cells, helping to destroy them. The dead cells are sometimes removed through
a bronchoscope several days later.

Of note, however, the perfect execution of such a sensitive task necessitates a 
proper, accurate and highly professional laser machine.

In this vein, the [Portable Surgery Laser System FDA SIFLASER-1.2A](https://sifsof.com/product/810-nm-portable-surgery-laser-system-fda-siflaser-1-2a/)
presents itself as one of the most recommended devices among surgeons viewing its
high efficacy in treating SCLC in particular.

To explain in more detail, this device’s blue laser light interacts better with 
the tissue components haemoglobin or melanin. At 980 nm (the high-level laser radiation
needed), the machine performs better and gentler cutting, even at lower power.

Accordingly, its improved cutting performance makes it ideally suited to all surgical
applications, particularly for cancer-related issues.

What also makes the SIFLASER-1.2A highly appreciated and recommended by surgeons
is that it displays an accurate alignment and exact sighting during the treatment.
All thanks to its green aiming beam.

To further improve the treatment, the device is supported with a fiber guide laser.
That is, it is compatible with various endoscopic uses. Also, these special fibers
are sterilisable which, in turn, prevents any possible cross-infection while guaranteeing
a clean and bloodless operative area.

With 980 nm wavelength and 15W as maximum power, the device is thought to perfectly
address SCLC issues. That is highly attributed to the fact that the SIFLASER-1.2
A uses infrared wavelengths and ultra-blue light to ensure high-level performance.
This, in return, is also estimated to reduce the thermal damage and its peculiar
interaction with haemoglobin.

Due to all these features, the SIFLASER-1.2 A guarantees increased cutting effectiveness,
much higher than the one obtained with infrared lasers.

Non-small-cell lung cancer (NSCLC) is the most common type of lung cancer, accounting
for roughly 85 percent of all cases. NSCLC is the out-of-control growth of cells
in the tissue of the lungs. These cells can form tumours and metastasis (spread)
to other areas of the body, becoming life-threatening. Fortunately, laser treatment
has been gradually developed to diagnose and treat this issue, especially since 
it proved to be a successful addition to cancer surgery in particular.

On this basis, we attempted to discuss the benefits of laser therapy and precisely
the efficacy of SIFLASER-1.2 A as a surgical laser device capable of efficiently
treating NSCLC problems.

Reference:[ Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version](https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#:~:text=NSCLC%20is%20any%20type%20of,occur%20in%20unusual%20histologic%20variants.)

 * ![Portable-surgery-diode-laser-system FDA SIFLASER-2.1A](https://sifsof.com/wp-
   content/uploads/2022/02/Portable-surgery-diode-laser-system-FDA-SIFLASER-2.1B-
   300x300.jpg)
 * 810 nm Portable Surgery Laser System FDA SIFLASER-1.2A

Disclaimer: Although the information we provide is used by different doctors and
medical staff to perform their procedures and clinical applications, the information
contained in this article is for consideration only. SIFSOF is not responsible neither
for the misuse of the device nor for the wrong or random generalizability of the
device in all clinical applications or procedures mentioned in our articles. Users
must have the proper training and skills to perform the procedure with each Laser
system.

The products mentioned in this article are only for sale to medical staff (doctors,
nurses, certified practitioners, etc.) or to private users assisted by or under 
the supervision of a medical professional.
